Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,479 papers from all fields of science
Search
Sign In
Create Free Account
AVE 0118
Known as:
AVE-0118
, AVE0118
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Biphenyl Compounds
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Antiarrhythmic effect of vernakalant in electrically remodeled goat atria is caused by slowing of conduction and prolongation of postrepolarization refractoriness.
A. van Hunnik
,
D. Lau
,
S. Zeemering
,
M. Kuiper
,
S. Verheule
,
U. Schotten
Heart Rhythm
2016
Corpus ID: 45587811
2014
2014
Homology modeling of Kv1.5 channel block by cationic and electroneutral ligands.
D. Tikhonov
,
B. Zhorov
Biochimica et Biophysica Acta
2014
Corpus ID: 33311577
Review
2012
Review
2012
Altered Excitation-Contraction Coupling in Human Chronic Atrial Fibrillation.
E. Grandi
,
A. Workman
,
S. Pandit
Journal of Atrial Fibrillation
2012
Corpus ID: 13301245
This review focuses on the (mal)adaptive processes in atrial excitation-contraction coupling occurring in patients with chronic…
Expand
Review
2009
Review
2009
Kv1.5 blockers for the treatment of atrial fibrillation: approaches to optimization of potency and selectivity and translation to in vivo pharmacology.
M. Bilodeau
,
B. Trotter
Current Topics in Medicinal Chemistry
2009
Corpus ID: 37410855
The treatment and prevention of atrial fibrillation (AF) remains a significant unmet medical need. Existing therapies that…
Expand
2009
2009
Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure
H. Schneider
,
Oliver Husser
,
+8 authors
A. Luchner
Naunyn-Schmiedeberg's Archives of Pharmacology
2009
Corpus ID: 2974341
Congestive heart failure (CHF) is often associated with atrial fibrillation. The safety of many antiarrhythmic drugs in CHF is…
Expand
2008
2008
Novel Transient Outward and Ultra-rapid Delayed Rectifier Current Antagonist, AVE0118, Protects Against Ventricular Fibrillation Induced by Myocardial Ischemia
G. Billman
,
Monica Kukielka
Journal of Cardiovascular Pharmacology
2008
Corpus ID: 21539625
AVE0118 is a novel drug that blocks the transient outward current (Ito), the ultra rapid component of the delayed rectifier…
Expand
2006
2006
Electrophysiological and antiarrhythmic effects of the novel antiarrhythmic agent AZD7009: a comparison with azimilide and AVE0118 in the acutely dilated right atrium of the rabbit in vitro.
L. Löfberg
,
I. Jacobson
,
L. Carlsson
Europace
2006
Corpus ID: 38446830
AIMS To compare the electrophysiological and antiarrhythmic effects of AZD7009, azimilide, and AVE0118 in the acutely dilated…
Expand
2006
2006
Properties of a Time-Dependent Potassium Current in Pig Atrium: Evidence for a Role of Kv1.5 in Repolarization
J. Ehrlich
,
C. Hoche
,
+5 authors
H. Gögelein
Journal of Pharmacology and Experimental…
2006
Corpus ID: 11897796
Cardiac electrical activity is modulated by potassium currents. Pigs have been used for antiarrhythmic drug testing, but only…
Expand
2006
2006
FRS-070 Efficacy of "Early" Class III Drug AVE0118 on Alcohol-related Atrial Tachyarrhythmias(Clinical Arrhythmia-1 (A) FRS14,Featured Research Session,The 70th Anniversary Annual Scientific Meeting…
Takeshi Kato
,
T. Yamashita
,
+4 authors
L. Fu
2006
Corpus ID: 68719620
2005
2005
The novel Ito/IKur blocker AVE0118, but not the Ikr blocker dofetilide, restores atrial contractility after cardioversion of atrial fibrillation in the goat
S. D. Haan
,
Y. Blaauw
,
+4 authors
U. Schotten
2005
Corpus ID: 72953316
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE